Filarial Parasites: Detailed Study Notes
Tissue Nematodes
- Introduction
- Filarial parasites are nematode parasites that primarily impact human and animal hosts.
Learning Outcomes
- Learn to list important human and animal filarial parasites.
- Differentiate their morphological characters.
- Describe their life cycles and biology.
- List clinical features and explain the pathogenesis of these infections.
- Describe laboratory diagnosis, treatment, and control of these infections.
Important Human and Animal Filarial Parasites
- Human Filarial Parasites:
- Wuchereria bancrofti
- Brugia malayi
- Brugia timori
- Brugia pahangi
- Tissue Dwelling Filarial Parasite:
- Onchocerca volvulus
- Animal Filarial Parasites:
- Dirofilaria immitis
- Dirofilaria repens
Microfilariae Features
Morphological characteristics of microfilariae:
- Sheathed vs Unsheathed Microfilariae:
- Wuchereria bancrofti: Sheathed, pointed tail, no nuclei extending to tail tip.
- Brugia malayi: Sheathed, blunt tail tip, two nuclei at tail tip.
- Onchocerca volvulus: Unsheathed, blunt tail tip, free of nuclei.
Flowchart defined by tail-end nuclei extensions distinguishing various microfilariae:
- Mansonella perstans, Mansonella streptocerca, Brugia malayi, Mansonella ozzardi, Wuchereria bancrofti, Loa loa.
Clinical Overview of Lymphatic Filariasis
- Prevalence and Impact:
- Affects 856 million people in 72 countries; 120 million are infected, with 40 million showing severe symptoms.
- Major affected countries: Bangladesh, Côte d'Ivoire, Democratic Republic of Congo, India, Indonesia, Myanmar, Nigeria, Nepal, Philippines, United Republic of Tanzania.
- Strains:
- 90% of cases are due to Wuchereria bancrofti.
- Periodic and sub-periodic strains of Brugia malayi.
Life Cycle of Lymphatic Filariasis
- Microfilariae enter circulation.
- Taken up by mosquitoes where they develop.
- Developed larvae (L3) migrate to the mosquito’s proboscis.
- Deposited on skin during feeding and enter host's lymphatics.
- Moulting occurs, developing into L4 and adult.
Clinical Features and Symptoms
- Wide range of symptoms:
- Asymptomatic, microfilaraemic, or chronic lymphatic pathology.
- Possible acute lymphangitis and chronic conditions includes lymphoedema, elephantiasis, and chyluria.
Diagnosis
- Clinical diagnosis based on:
- Detection of microfilariae.
- Histological evidence of parasites.
- Specific antifilarial antibodies and antigens.
Treatment
- Common Treatments:
- Diethylcarbamazine citrate (DEC): Kills adult worms and microfilariae.
- Albendazole: Kills adult worms; usually administered with DEC.
- Ivermectin: Primarily targets microfilariae.
- Additional use of Doxycycline to clear Wolbachia bacteria associated with parasites.
- WHO Recommendations:
- A combined treatment known as IDA (Ivermectin, DEC, and Albendazole) to eliminate lymphatic filariasis more effectively.
Onchocerciasis (River Blindness)
- Overview:
- Caused by Onchocerca volvulus, affecting about 25 million worldwide, with 300,000 blind and 800,000 with visual impairment.
- Life Cycle:
- Infection occurs through bites of blackflies (e.g., Simulium spp.), with emerging microfilariae presented in skin after interaction.
Clinical Features of Onchocerciasis
- Symptoms develop 1-3 years post-infection:
- Onchocercomas over bony prominences.
- Intense itchiness, skin depigmentation, lymphadenitis.
- Severe complications include elephantiasis of genitals and blindness from inflammation by Wolbachia.
Diagnosis and Treatment of Onchocerciasis
- Diagnosis:
- Based on clinical presence of onchocercomas and microfilariae in skin.
- Treatment:
- Ivermectin at 200 μg/kg to kill microfilariae.
- Doxycycline to target Wolbachia.
- Nodulectomy may be performed to remove adult worms.
Control Strategies
- Control vector breeding using aerial insecticides.
- Annual mass treatment with Ivermectin.
- Nodulectomy helps reduce worm levels.
- Focus on reducing contact between humans and vector flies.
Dirofilaria spp.
- Commonly known as Heartworms in dogs, primarily affect canines but occasionally humans.
- Present as either subcutaneous or pulmonary infections in humans, with treatments available such as Ivermectin and DEC for control.
Conclusion
- Understanding the life cycles, clinical features, treatment and control of these filarial parasites are critical for effective management of these infections among both human and animal populations.